Perceptive Advisors LLC Verona Pharma PLC Call Options Transaction History
Perceptive Advisors LLC
- $3 Billion
- Q4 2024
Call Options
2 transactions
Others Institutions Holding VRNA
# of Institutions
217Shares Held
70.5MCall Options Held
1.4MPut Options Held
299K-
Nea Management Company, LLC Timonium, MD5.58MShares$359 Million18.53% of portfolio
-
Frazier Life Sciences Management, L.P. Menlo Park, CA3.38MShares$217 Million9.42% of portfolio
-
Eventide Asset Management, LLC Boston, MA3.13MShares$201 Million2.79% of portfolio
-
Lee Ainslie Maverick Capital LTD | Dallas, Tx3.13MShares$201 Million2.81% of portfolio
-
Wellington Management Group LLP Boston, MA3.03MShares$194 Million0.03% of portfolio
About Verona Pharma plc
- Ticker VRNA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 60,954,200
- Market Cap $3.92B
- Description
- Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...